Albert Einstein College of Medicine - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- GDPH69456D
- Pages: 47
- September 2018
- Total Views:1146
- Region : North America
- GlobalData
- Equity Research Report
Details
Summary
Albert Einstein College of Medicine (AECM) a subsidiary of Montefiore Medical Center is a healthcare service provider that offers educational services. The institute operates as a research institute for medical education, basic research and clinical investigation. It offers education programs such as graduate medical education, graduate program, masters in bioethics, master of public health, medical program, masters in clinical research and MSTP program, among others. AECM provides its courses through departments such as anatomy structural biology, anesthesiology, biochemistry, cardiovascular and thoracic surgery, cell biology, dentistry, development and molecular biology. The institute also operates through departments including emergency medicine, genetics, medicine, microbiology and immunology, molecular pharmacology, pediatrics, physiology and biophysics and radiation oncology. AECM is headquartered in Bronx, New York, the US.
Albert Einstein College of Medicine-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table Of Content
Scope
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Albert Einstein College of Medicine, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Albert Einstein College of Medicine, Medical Devices Deals, 2012 to YTD 2018 10
Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
MetaStat Enters Into Licensing Agreement With Albert Einstein College of Medicine For Metastatic Cell Technology Patents 12
Immune-Onc Therapeutics Enters into Research Agreement with Albert Einstein College of Medicine 13
Jiangsu Hengrui Medicine to Form Partnership With Albert Einstein College of Medicine 14
Actinium Pharma Enters into Co-Development Agreement with Albert Einstein College of Medicine 15
Licensing Agreements 16
Immune-Onc Therapeutics Enters into Licensing Agreement with Albert Einstein College of Medicine and Memorial Sloan Kettering Cancer Center 16
Cue Biopharma Amends License Agreement with Albert Einstein 17
Nexus BioPharma Enters into Licensing Agreement with Albert Einstein College of Medicine 18
MetaStat Enters Into Licensing Agreements For Alternative Splicing Program 19
Albert Einstein College of Medicine-Key Competitors 21
Albert Einstein College of Medicine-Key Employees 22
Albert Einstein College of Medicine-Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 24
Government and Public Interest 24
Jun 03, 2018: TAILORx Trial Finds Most Women with Early Breast Cancer Do Not Benefit from Chemotherapy 24
May 14, 2018: Einstein and Montefiore Awarded USD 25 Million from the NIH to Continue Its Institute for Clinical and Translational Research 26
Nov 29, 2017: Einstein Receives USD 174 Million in Fiscal Year 2017 28
Nov 27, 2017: Increased Oral Pathogens and Decreased Bacterial Diversity Predict Precancerous Lesions of Stomach Cancer 29
Nov 14, 2017: Einstein researchers receive USD 6 million grant to untangle the genetic protections against Alzheimer's disease 30
Nov 06, 2017: NIH Funds Research to Fight Alzheimer's Disease with Anti-Inflammatory Diet 31
Oct 19, 2017: Study Shows How Nerves Drive Prostate Cancer 32
Oct 16, 2017: Einstein Researchers Share USD 9 Million Grant to Find Anti-Aging Therapies 33
Oct 16, 2017: Scripps Florida Scientists Share USD 9 Million Grant to Develop Therapies that Target the Aging Process 34
Oct 09, 2017: Novel Treatment Causes Cancer to Self-Destruct Without Affecting Healthy Cells 35
Oct 06, 2017: FDA awards 15 grants for clinical trials to stimulate product development for rare diseases 37
Aug 22, 2017: Einstein Researchers Awarded USD 3 Million for Longevity and Aging Studies 39
Aug 08, 2017: First Long-Term Study on Medical Marijuana's Impact on Opioid Use for Pain 40
Jul 12, 2017: Montefiore And Einstein Awarded USD 3.4 Million NIH Grant To Integrate Opioid And Tobacco Addiction Treatment 41
Jun 09, 2017: NIH Funds NYC Center for AIDS Research 42
Jan 20, 2017: South African Study Provides Compelling New Evidence on Role of Person-to Person Transmission in Drug-Resistant TB Epidemics 43
Other Significant Developments 44
Aug 09, 2018: Ebola virus experts discover powerful, new approach for future therapeutics 44
May 30, 2018: Montefiore And Einstein Break Barriers With First Picture-Based Dementia Screening Tool 46
Appendix 47
Methodology 47
About GlobalData 47
Contact Us 47
Disclaimer 47
List Of Figure
List of Figures
Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Albert Einstein College of Medicine, Medical Devices Deals, 2012 to YTD 2018 10
List Of Table
List of Tables
Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Key Facts 2
Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Albert Einstein College of Medicine, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Albert Einstein College of Medicine, Deals By Therapy Area, 2012 to YTD 2018 9
Albert Einstein College of Medicine, Medical Devices Deals, 2012 to YTD 2018 10
Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
MetaStat Enters Into Licensing Agreement With Albert Einstein College of Medicine For Metastatic Cell Technology Patents 12
Immune-Onc Therapeutics Enters into Research Agreement with Albert Einstein College of Medicine 13
Jiangsu Hengrui Medicine to Form Partnership With Albert Einstein College of Medicine 14
Actinium Pharma Enters into Co-Development Agreement with Albert Einstein College of Medicine 15
Immune-Onc Therapeutics Enters into Licensing Agreement with Albert Einstein College of Medicine and Memorial Sloan Kettering Cancer Center 16
Cue Biopharma Amends License Agreement with Albert Einstein 17
Nexus BioPharma Enters into Licensing Agreement with Albert Einstein College of Medicine 18
MetaStat Enters Into Licensing Agreements For Alternative Splicing Program 19
Albert Einstein College of Medicine, Key Competitors 21
Albert Einstein College of Medicine, Key Employees 22
Albert Einstein College of Medicine, Subsidiaries 23
Licence Rights
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
Section Purchase
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products and Companies
Products
Albert Einstein College of Medicine, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Company Profile
Company Profile Title
Summary
Albert Einstein College of Medicine (AECM) a subsidiary of Montefiore Medical Center is a healthcare service provider that offers educational services. The institute operates as a research institute for medical education, basic research and clinical investigation. It offers education programs such as graduate medical education, graduate program, masters in bioethics, master of public health, medical program, masters in clinical research and MSTP program, among others. AECM provides its courses through departments such as anatomy structural biology, anesthesiology, biochemistry, cardiovascular and thoracic surgery, cell biology, dentistry, development and molecular biology. The institute also operates through departments including emergency medicine, genetics, medicine, microbiology and immunology, molecular pharmacology, pediatrics, physiology and biophysics and radiation oncology. AECM is headquartered in Bronx, New York, the US.
Albert Einstein College of Medicine-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Scope
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Albert Einstein College of Medicine, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Albert Einstein College of Medicine, Medical Devices Deals, 2012 to YTD 2018 10
Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
MetaStat Enters Into Licensing Agreement With Albert Einstein College of Medicine For Metastatic Cell Technology Patents 12
Immune-Onc Therapeutics Enters into Research Agreement with Albert Einstein College of Medicine 13
Jiangsu Hengrui Medicine to Form Partnership With Albert Einstein College of Medicine 14
Actinium Pharma Enters into Co-Development Agreement with Albert Einstein College of Medicine 15
Licensing Agreements 16
Immune-Onc Therapeutics Enters into Licensing Agreement with Albert Einstein College of Medicine and Memorial Sloan Kettering Cancer Center 16
Cue Biopharma Amends License Agreement with Albert Einstein 17
Nexus BioPharma Enters into Licensing Agreement with Albert Einstein College of Medicine 18
MetaStat Enters Into Licensing Agreements For Alternative Splicing Program 19
Albert Einstein College of Medicine-Key Competitors 21
Albert Einstein College of Medicine-Key Employees 22
Albert Einstein College of Medicine-Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 24
Government and Public Interest 24
Jun 03, 2018: TAILORx Trial Finds Most Women with Early Breast Cancer Do Not Benefit from Chemotherapy 24
May 14, 2018: Einstein and Montefiore Awarded USD 25 Million from the NIH to Continue Its Institute for Clinical and Translational Research 26
Nov 29, 2017: Einstein Receives USD 174 Million in Fiscal Year 2017 28
Nov 27, 2017: Increased Oral Pathogens and Decreased Bacterial Diversity Predict Precancerous Lesions of Stomach Cancer 29
Nov 14, 2017: Einstein researchers receive USD 6 million grant to untangle the genetic protections against Alzheimer's disease 30
Nov 06, 2017: NIH Funds Research to Fight Alzheimer's Disease with Anti-Inflammatory Diet 31
Oct 19, 2017: Study Shows How Nerves Drive Prostate Cancer 32
Oct 16, 2017: Einstein Researchers Share USD 9 Million Grant to Find Anti-Aging Therapies 33
Oct 16, 2017: Scripps Florida Scientists Share USD 9 Million Grant to Develop Therapies that Target the Aging Process 34
Oct 09, 2017: Novel Treatment Causes Cancer to Self-Destruct Without Affecting Healthy Cells 35
Oct 06, 2017: FDA awards 15 grants for clinical trials to stimulate product development for rare diseases 37
Aug 22, 2017: Einstein Researchers Awarded USD 3 Million for Longevity and Aging Studies 39
Aug 08, 2017: First Long-Term Study on Medical Marijuana's Impact on Opioid Use for Pain 40
Jul 12, 2017: Montefiore And Einstein Awarded USD 3.4 Million NIH Grant To Integrate Opioid And Tobacco Addiction Treatment 41
Jun 09, 2017: NIH Funds NYC Center for AIDS Research 42
Jan 20, 2017: South African Study Provides Compelling New Evidence on Role of Person-to Person Transmission in Drug-Resistant TB Epidemics 43
Other Significant Developments 44
Aug 09, 2018: Ebola virus experts discover powerful, new approach for future therapeutics 44
May 30, 2018: Montefiore And Einstein Break Barriers With First Picture-Based Dementia Screening Tool 46
Appendix 47
Methodology 47
About GlobalData 47
Contact Us 47
Disclaimer 47
List Of Figure
List of Figures
Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Albert Einstein College of Medicine, Medical Devices Deals, 2012 to YTD 2018 10
List Of Table
List of Tables
Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Key Facts 2
Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Albert Einstein College of Medicine, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Albert Einstein College of Medicine, Deals By Therapy Area, 2012 to YTD 2018 9
Albert Einstein College of Medicine, Medical Devices Deals, 2012 to YTD 2018 10
Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
MetaStat Enters Into Licensing Agreement With Albert Einstein College of Medicine For Metastatic Cell Technology Patents 12
Immune-Onc Therapeutics Enters into Research Agreement with Albert Einstein College of Medicine 13
Jiangsu Hengrui Medicine to Form Partnership With Albert Einstein College of Medicine 14
Actinium Pharma Enters into Co-Development Agreement with Albert Einstein College of Medicine 15
Immune-Onc Therapeutics Enters into Licensing Agreement with Albert Einstein College of Medicine and Memorial Sloan Kettering Cancer Center 16
Cue Biopharma Amends License Agreement with Albert Einstein 17
Nexus BioPharma Enters into Licensing Agreement with Albert Einstein College of Medicine 18
MetaStat Enters Into Licensing Agreements For Alternative Splicing Program 19
Albert Einstein College of Medicine, Key Competitors 21
Albert Einstein College of Medicine, Key Employees 22
Albert Einstein College of Medicine, Subsidiaries 23
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products
Albert Einstein College of Medicine, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Ask A Question
Our Team Will Assist You in What You Are Looking For
or 
: +91 98100 26150
: ankurgupta1984
Related Reports
Page 130 | 
March 2021
Page 140 | November 2020
Page 99 | July 2020
Page 75 | July 2020
Page 114 | May 2020